Clinical Trials Browser

Breast Neoplasms × pyrotinib × Gastrointestinal × Clear all

NCT02500199 2021-02-01

Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors

Phase 1 Unknown

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms